As of May 3, 2018 VITALITY BIOPHARMA INC (OTCMKTS:VBIO) Shorts Reduced By 20.16%

May 3, 2018 - By Sarah Holford

It was recorded a decrease on VITALITY BIOPHARMA INC (OTCMKTS:VBIO)’s short interest with 20.16%. FINRA issued in May VBIO’s total 257,800 short interest. That’s 20.16% down from 322,900 shares. With Average volume 205,300, VBIO’s previous position will take 1 days to recover. VITALITY BIOPHARMA INC’s short interest float is 1.38%.

VBIO is hitting $1.52 during the last trading session, after increased 0.66%.Currently Vitality Biopharma, Inc. is after 0.00% change in last May 3, 2017. VBIO has 1,328 shares volume. VBIO underperformed by 11.55% the S&P500.

Vitality Biopharma, Inc. focuses on the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States.The firm is worth $34.19 million. The Company’s products in pipeline include VITA-100, an oral cannabinoid formulation that is used for the acute treatment of inflammatory bowel disease and narcotic bowel syndrome; and VITA-210, a cannabinoid formulation, which is in preclinical studies for use in the chronic treatment of neuropathic pain, irritable bowel syndrome, muscle spasticity in multiple sclerosis, and opioid-induced bowel dysfunction.Last it reported negative earnings. The firm was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.